Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer
Study Details
Study Description
Brief Summary
This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. Liver function test, renal function test, and adverse event will be assessed.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This study will be evaluated safety of undenatured collagen type II (UCII) supplement in 60 healthy volunteer. The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months. Liver function test, renal function test, and adverse event will be assessed before and after taking for 1 and 2 months.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: undenatured collagen type II (UCII) supplement The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months. |
Dietary Supplement: undenatured collagen type II (UCII) supplement
The undenatured collagen type II (UCII) supplement 40 mg will be taken once daily for 2 months.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Aspartate aminotransferase value [2 months]
Aspartate aminotransferase value (U/L) in blood sample
Secondary Outcome Measures
- Alkaline phosphatase value [2 months]
Alkaline phosphatase value (U/L) in blood sample
- Alanine transaminase value [2 months]
Alanine transaminase value(U/L) in blood sample
- Blood urea nitrogen value [2 months]
Blood urea nitrogen value (mg/dl) in blood sample
- Creatinine value [2 months]
Creatinine value (mg/dl) in blood sample
- Adverse event [2 months]
using questionnaire (Yes or No)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 20-60 years
-
No taking collagen supplement more than 2 weeks
-
No collagen and protein allergy
-
No liver and renal disease
-
Have a willingness to participate in the study
Exclusion Criteria:
-
Uncontrolled disease
-
Have complication symptom during study
-
Pregnancy or lactation
-
Cannot follow the protocol
-
During participated in other studies
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Chulalongkorn University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- EC2104220